Click for best price
Postpemic Era Cholera Vaccines Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Post-pandemic Era-Global Cholera Vaccines Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate?, which aims to sort out the development status and trends of the Cholera Vaccines industry at home and abroad, estimate the overall market scale of the Cholera Vaccines industry and the market share of major countries, Cholera Vaccines industry, and study and judge the downstream market demand of Cholera Vaccines through systematic research, Analyze the competition pattern of Cholera Vaccines, so as to help solve the pain points of various stakeholders in Cholera Vaccines industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018- 2028) of Cholera Vaccines Market by Research Include
NorthAmerica
Asia
Europe
Middle East & Africa
South America
Competitive Analysis; Who are the Major Players in Cholera Vaccines Market?
Shantha Biotechnics Private Limited
PaxVax, Inc.
Valneva SE
Merck and Co., Inc.
GlaxoSmithKline plc (GSK)
Astellas Pharma, Inc.
Pfizer, Inc.
Emergent BioSolutions, Inc.
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Co., Ltd.
Major Type of Cholera Vaccines Covered in Research report:
Dukoral
Shanchol
Vaxchora
Others
Application Segments Covered in Research Market
Oral
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
Post-pandemic Era-Global Cholera Vaccines Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
84 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Post-pandemic Era-Global Cholera Vaccines Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Dukoral -Product Introduction and Major Company
1.1.2 Shanchol -Product Introduction and Major Company
1.1.3 Vaxchora -Product Introduction and Major Company
1.1.4 Others -Product Introduction and Major Company
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Five-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Sales (2018 & 2022 & 2026)
2.2 Regional Market Share in Terms of Revenue (2018 & 2022 & 2026)
2.3 Regional Market Share in Terms of Consumption (2018 & 2022 & 2026)
3 Global Cholera Vaccines Market Assessment by Type
3.1 Global Cholera Vaccines Sales by Type (2018-2028)
3.2 Global Cholera Vaccines Revenue by Type (2018-2028)
3.3 North America Cholera Vaccines Sales and Revenue by Type (2018-2028)
3.4 Asia Cholera Vaccines Sales and Revenue by Type (2018-2028)
3.5 Europe Cholera Vaccines Sales and Revenue by Type (2018-2028)
3.6 Middle East & Africa Cholera Vaccines Sales and Revenue by Type (2018-2028)
3.7 South America Cholera Vaccines Sales and Revenue by Type (2018-2028)
4 Historical & Forecast Global Cholera Vaccines Market Assessment by Application
4.1 Global Cholera Vaccines Consumption and Consumption in Different Application Field (2018-2028)
4.2 North America Cholera Vaccines Consumption and Consumption in Different Application Field (2018-2028)
4.3 Asia Cholera Vaccines Consumption and Consumption in Different Application Field (2018-2028)
4.4 Europe Cholera Vaccines Consumption and Consumption in Different Application Field (2018-2028)
4.5 Middle East & Africa Cholera Vaccines Consumption and Consumption in Different Application Field (2018-2028)
4.6 South America Cholera Vaccines Consumption and Consumption in Different Application Field (2018-2028)
5 North America
5.1 US Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
5.2 Canada Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
5.3 Mexico Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
6 Asia
6.1 China Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
6.2 Japan Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
6.3 India Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
6.4 Korea Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
6.5 Southeat Asia Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
7 Europe
7.1 Germany Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
7.2 UK Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
7.3 France Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
7.4 Russia Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
7.5 Italy Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
8 Middle East and Africa
8.1 Saudi Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
8.2 UAE Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
8.3 Egypt Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
8.4 Nigeria Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
8.5 South Africa Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
9 South America
9.1 Brazil Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
9.2 Argentina Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
9.3 Colombia Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
10 Global Cholera Vaccines Average Price Trend
10.1 Market Price for Each Type of Cholera Vaccines in North America (2018-2028)
10.2 Market Price for Each Type of Cholera Vaccines in Asia (2018-2028)
10.3 Market Price for Each Type of Cholera Vaccines in Europe (2018-2028)
10.4 Market Price for Each Type of Cholera Vaccines in Middle East & Africa (2018-2028)
10.5 Market Price for Each Type of Cholera Vaccines in South America (2018-2028)
11 Value Chain
11.1 Cholera Vaccines Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Cholera Vaccines Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.2.2 Post-pandemic Era
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Major Players of Global Cholera Vaccines Market, Competitive Analysis
12.1 Shantha Biotechnics Private Limited
12.1.1 Shantha Biotechnics Private Limited Company Profiles and Company News
12.1.2 Shantha Biotechnics Private Limited Product Introduction
12.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Sales, Revenue (2018-2022)
12.1.4 SWOT Analysis
12.2 PaxVax, Inc.
12.2.1 PaxVax, Inc. Company Profiles and Company News
12.2.2 PaxVax, Inc. Product Introduction
12.2.3 PaxVax, Inc. Cholera Vaccines Sales, Revenue (2018-2022)
12.2.4 SWOT Analysis
12.3 Valneva SE
12.3.1 Valneva SE Company Profiles and Company News
12.3.2 Valneva SE Product Introduction
12.3.3 Valneva SE Cholera Vaccines Sales, Revenue (2018-2022)
12.3.4 SWOT Analysis
12.4 Merck and Co., Inc.
12.4.1 Merck and Co., Inc. Company Profiles and Company News
12.4.2 Merck and Co., Inc. Product Introduction
12.4.3 Merck and Co., Inc. Cholera Vaccines Sales, Revenue (2018-2022)
12.4.4 SWOT Analysis
12.5 Mitsubishi Tanabe Pharma Corporation
12.5.1 GlaxoSmithKline plc (GSK) Company Profiles and Company News
12.5.2 GlaxoSmithKline plc (GSK) Product Introduction
12.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Sales, Revenue (2018-2022)
12.5.4 SWOT Analysis
12.6 Astellas Pharma, Inc.
12.6.1 Astellas Pharma, Inc. Company Profiles and Company News
12.6.2 Astellas Pharma, Inc. Product Introduction
12.6.3 Astellas Pharma, Inc. Cholera Vaccines Sales, Revenue (2018-2022)
12.6.4 SWOT Analysis
12.7 Pfizer, Inc.
12.7.1 Pfizer, Inc. Company Profiles and Company News
12.7.2 Pfizer, Inc. Product Introduction
12.7.3 Pfizer, Inc. Cholera Vaccines Sales, Revenue (2018-2022)
12.7.4 SWOT Analysis
12.8 Emergent BioSolutions, Inc.
12.8.1 Emergent BioSolutions, Inc. Company Profiles and Company News
12.8.2 Emergent BioSolutions, Inc. Product Introduction
12.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Sales, Revenue (2018-2022)
12.8.4 SWOT Analysis
12.9 Mitsubishi Tanabe Pharma Corporation
12.9.1 Mitsubishi Tanabe Pharma Corporation Company Profiles and Company News
12.9.2 Mitsubishi Tanabe Pharma Corporation Product Introduction
12.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Sales, Revenue (2018-2022)
12.9.4 SWOT Analysis
12.10 Takeda Pharmaceutical Co., Ltd.
12.10.1 Takeda Pharmaceutical Co., Ltd. Company Profiles and Company News
12.10.2 Takeda Pharmaceutical Co., Ltd. Product Introduction
12.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Sales, Revenue (2018-2022)
12.10.4 SWOT Analysis
13 Global Cholera Vaccines Market, Competitive Landscape and Market Forecast
13.1 Key Companies Dominating the Global Cholera Vaccines Market
13.2 Concentration Ratio (CR5) of Global Cholera Vaccines Market (2018)
13.2.1 Market Share of Top 5 Players in Term of Revenue (2018)
13.3 Concentration Ratio (CR5) of Global Cholera Vaccines Market (2022)
13.3.1 Market Share of Top 5 Players in Term of Revenue (2022)
14 Conclusion
15 Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure Product Introduction
Table Sales (K Units) and Revenue (Million USD) of Major Players (2018-2022)
Figure Global Cholera Vaccines Sales Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Sales of Each Type (2018-2028)
Table Regional Market Share in Terms of Sales (2019-2026)
Figure Regional Market Share in Terms of Sales (2019 - 2020)
Table Regional Market Share in Terms of Revenue (2019-2026)
Figure Regional Market Share in Terms of Revenue (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Table Global Cholera Vaccines Sales (K Unit) by Type (2018-2028)
Figure Global Cholera Vaccines Sales (K Unit) and Growth Rate (2018-2028)
Figure Global Cholera Vaccines Sales Market Share (%) by Type (2019 -2020)
Table Global Cholera Vaccines Revenue (Million USD) by Type (2018-2028)
Figure Global Cholera Vaccines Revenue (Million USD) and Growth Rate (2018-2028)
Figure Global Cholera Vaccines Revenue Market Share (%) by Type (2019-2020)
Figure North America Cholera Vaccines Sales (K Unit) by Type (2018-2028)
Figure North America Cholera Vaccines Sales (K Unit) and Growth Rate (2018-2028)
Figure North America Cholera Vaccines Revenue (Million USD) by Type (2018-2028)
Figure North America Cholera Vaccines Revenue (Million USD) and Growth Rate (2018-2028)
Figure Asia Cholera Vaccines Sales (K Unit) by Type (2018-2028)
Figure Asia Cholera Vaccines Sales (K Unit) and Growth Rate (2018-2028)
Figure Asia Cholera Vaccines Revenue (Million USD) by Type (2018-2028)
Figure Asia Cholera Vaccines Revenue (Million USD) and Growth Rate (2018-2028)
Figure Europe Cholera Vaccines Sales (K Unit) by Type (2018-2028)
Figure Europe Cholera Vaccines Sales (K Unit) and Growth Rate (2018-2028)
Figure Europe Cholera Vaccines Revenue (Million USD) by Type (2018-2028)
Figure Europe Cholera Vaccines Revenue (Million USD) and Growth Rate (2018-2028)
Figure Middle East & Africa Cholera Vaccines Sales (K Unit) by Type (2018-2028)
Figure Middle East & Africa Cholera Vaccines Sales (K Unit) and Growth Rate (2018-2028)
Figure Middle East & Africa Cholera Vaccines Revenue (Million USD) by Type (2018-2028)
Figure Middle East & Africa Cholera Vaccines Revenue (Million USD) and Growth Rate (2018-2028)
Figure South America Cholera Vaccines Sales (K Unit) by Type (2018-2028)
Figure South America Cholera Vaccines Sales (K Unit) and Growth Rate (2018-2028)
Figure South America Cholera Vaccines Revenue (Million USD) by Type (2018-2028)
Figure South America Cholera Vaccines Revenue (Million USD) and Growth Rate (2018-2028)
Table Historical & Forecast Cholera Vaccines Different Application Field Consumption (K Unit)
Figure Consumption (K Unit) and Growth Rate (2018-2028)
Figure Different Application Field Consumption Market Share (%) (2019-2020)
Table Historical & Forecast Cholera Vaccines Different Application Field Consumption (K Unit)
Figure North America Cholera Vaccines Consumption (K Unit) and Growth Rate (2018-2028)
Figure North America Cholera Vaccines Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Cholera Vaccines Different Application Field Consumption (K Unit)
Figure Asia Cholera Vaccines Consumption (K Unit) and Growth Rate (2018-2028)
Figure Asia Cholera Vaccines Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Cholera Vaccines Different Application Field Consumption (K Unit)
Figure Europe Cholera Vaccines Consumption (K Unit) and Growth Rate (2018-2028)
Figure Europe Cholera Vaccines Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Cholera Vaccines Different Application Field Consumption (K Unit)
Figure Middle East & Africa Cholera Vaccines Consumption (K Unit) and Growth Rate (2018-2028)
Figure Middle East & Africa Cholera Vaccines Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Cholera Vaccines Different Application Field Consumption (K Unit)
Figure South America Cholera Vaccines Consumption (K Unit) and Growth Rate (2018-2028)
Figure South America Cholera Vaccines Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Cholera Vaccines Different Application Field Consumption (K Unit)
Table US Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Canada Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Mexico Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table China Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Japan Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table India Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Korea Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Southeast Asia Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Germany Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UK Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table France Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Russia Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Italy Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Saudi Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UAE Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Egypt Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Nigeria Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table South Africa Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Brazil Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Argentina Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Colombia Cholera Vaccines Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Market Price (USD/Unit) for Each Type of Cholera Vaccines in China
Table Market Price (USD/Unit) for Each Type of Cholera Vaccines in EU
Table Market Price (USD/Unit) for Each Type of Cholera Vaccines in USA
Table Market Price (USD/Unit) for Each Type of Cholera Vaccines in Japan
Table Market Price (USD/Unit) for Each Type of Cholera Vaccines in India
Table Market Price (USD/Unit) for Each Type of Cholera Vaccines in Southeast Asia
Table Market Price (USD/Unit) for Each Type of Cholera Vaccines in South America
Figure Value Chain Structure of Cholera Vaccines
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Cholera Vaccines
Figure Cost Structure of Cholera Vaccines in 2020
Table Distributors/Traders List
Table Shantha Biotechnics Private Limited Profiles
Table Shantha Biotechnics Private Limited Cholera Vaccines Product Introduction
Figure Shantha Biotechnics Private Limited Cholera Vaccines Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Shantha Biotechnics Private Limited SWOT Analysis
Table PaxVax, Inc. Profiles
Table PaxVax, Inc. Cholera Vaccines Product Introduction
Figure PaxVax, Inc. Cholera Vaccines Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure PaxVax, Inc. SWOT Analysis
Table Valneva SE Profiles
Table Valneva SE Cholera Vaccines Product Introduction
Figure Valneva SE Cholera Vaccines Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Valneva SE SWOT Analysis
Table Merck and Co., Inc. Profiles
Table Merck and Co., Inc. Cholera Vaccines Product Introduction
Figure Merck and Co., Inc. Cholera Vaccines Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Merck and Co., Inc. SWOT Analysis
Table GlaxoSmithKline plc (GSK) Profiles
Table GlaxoSmithKline plc (GSK) Cholera Vaccines Product Introduction
Figure GlaxoSmithKline plc (GSK) Medical Devices & Consumables Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure GlaxoSmithKline plc (GSK) SWOT Analysis
Table Astellas Pharma, Inc. Profiles
Table Astellas Pharma, Inc. Cholera Vaccines Product Introduction
Figure Astellas Pharma, Inc. Cholera Vaccines Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Astellas Pharma, Inc. SWOT Analysis
Table Pfizer, Inc. Profiles
Table Pfizer, Inc. Cholera Vaccines Product Introduction
Figure Pfizer, Inc. Cholera Vaccines Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Pfizer, Inc. SWOT Analysis
Table Emergent BioSolutions, Inc. Profiles
Table Emergent BioSolutions, Inc. Cholera Vaccines Product Introduction
Figure Emergent BioSolutions, Inc. Cholera Vaccines Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Emergent BioSolutions, Inc. SWOT Analysis
Table Mitsubishi Tanabe Pharma Corporation Profiles
Table Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Introduction
Figure Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Mitsubishi Tanabe Pharma Corporation SWOT Analysis
Table Takeda Pharmaceutical Co., Ltd. Profiles
Table Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Introduction
Figure Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Takeda Pharmaceutical Co., Ltd. SWOT Analysis
